small cell carcinoma
Showing 1 - 10 of 10
Quantifying Systemic Immunosuppression to Personalize Cancer
Recruiting
- Melanoma
- +6 more
- MDSC quantification
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Nov 11, 2022
Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)
Recruiting
- Adenocarcinoma
- +75 more
- Biomarker Testing (L)
- +2 more
-
Idaho Falls, Idaho
- +1 more
Oct 18, 2022
Small Cell Carcinoma, NSCLC, Neuroendocrine Tumors Trial in United States (RRx-001, Cisplatin, Etoposide)
Active, not recruiting
- Small Cell Carcinoma
- +3 more
- RRx-001
- +11 more
-
Palo Alto, California
- +9 more
May 12, 2022
Small Cell Neuroendocrine Carcinoma, Prostate Cancer, Small Cell Carcinoma Trial in San Francisco (Apalutamide, Cetrelimab)
Recruiting
- Small Cell Neuroendocrine Carcinoma
- +2 more
- Apalutamide
- Cetrelimab
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 21, 2022
Small Cell Carcinoma Trial in Seattle (Nortriptyline Hydrochloride, Paclitaxel)
Completed
- Small Cell Carcinoma
- Nortriptyline Hydrochloride
- Paclitaxel
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 16, 2019
Extensive Stage Small Cell Lung Carcinoma, Large Cell Lung Carcinoma, Neuroendocrine Carcinoma Trial in United States
Completed
- Extensive Stage Small Cell Lung Carcinoma
- +4 more
- Cisplatin
- +3 more
-
Loma Linda, California
- +427 more
Jan 17, 2019
Lung Tumor, Small Cell Carcinoma Trial in Edmonton (hypofractionated external beam)
Completed
- Lung Neoplasm
- Small Cell Carcinoma
- hypofractionated external beam
-
Edmonton, Alberta, CanadaCross Cancer Institute
Feb 24, 2016
Cone Beam CT Scanning in Lung and Bladder Cancer.
Completed
- Lung Neoplasm
- +2 more
-
Edmonton, Alberta, CanadaCross Cancer Institute
Feb 23, 2016
Lung Tumor, Small Cell Carcinoma Trial in Edmonton (Hypofractionated Chest Radiotherapy)
Completed
- Lung Neoplasm
- Small Cell Carcinoma
- Hypofractionated Chest Radiotherapy
-
Edmonton, Alberta, CanadaCross Cancer Institute
Feb 18, 2016